Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
LY2
HR+
Luminal
Gemcitabine
DNA replication
DNA replication
9536.011
uM
0.03769
0.01732
0.4261 0.4619 3.3111 0.3847
0.9569
1.2640
LY2
HR+
Luminal
Gemcitabine
DNA replication
DNA replication
10264.011
uM
0.01515
0.00980
0.4029 0.4434 5.0000 0.4053
0.9814
1.3983
LY2
HR+
Luminal
Glycyl-H-1152
ROCK2
12319.169
uM
0.10975
2.69160
-0.4744 -1.0000 0.3434 0.6374
0.8878
0.9948
LY2
HR+
Luminal
Glycyl-H-1152
ROCK2
10816.15
uM
1.03120
1.75740
-0.9598 -0.9331 1.9753 0.3994
0.9955
0.3031
LY2
HR+
Luminal
GSK1070916
AURK
AURK
10264.001
uM
9.11390
14.85550
-0.7214 -0.9999 2.2485 0.1714
0.9881
1.5356
LY2
HR+
Luminal
GSK1838705A
IGF1R
RTK
7477.098
uM
2.130
2.42270
-0.7323 -0.4519 5.0000 0.5164
0.8510
1.4247
LY2
HR+
Luminal
GSK1838705A
IGF1R
RTK
7477.091
uM
0.67592
1.69210
-0.9946 -1.0000 1.1972 0.6859
0.9762
1.1485
LY2
HR+
Luminal
GSK1838705A
IGF1R
RTK
7477.071
uM
0.62597
1.35510
-1.0000 -0.9841 1.4086 0.6625
0.9893
0.5122
LY2
HR+
Luminal
GSK1838705A
IGF1R
RTK
10380.092
uM
0.46366
0.42214
0.1747 0.1872 5.0000 0.3130
0.9930
1.4888
LY2
HR+
Luminal
GSK461364
PLK1
PLK
10264.001
uM
1.5220
12.28790
-0.5051 -1.0000 0.5260 0.3393
0.7954
1.5356
LY2
HR+
Luminal
GSK923295
CENPE
Kinesin
10264.001
uM
2.16170
56.86920
-0.0483 -1.0000 0.3360 0.2627
0.8398
1.5356
LY2
HR+
Luminal
Ibandronate
FDPS
12319.143
uM
54.84830
90.60060
-0.9785 -0.9712 2.1503 0.5591
0.8637
0.5178
LY2
HR+
Luminal
Ibandronate
FDPS
10816.143
uM
120.21070
144.11240
-0.7303 -0.7380 4.9993 0.2822
0.9954
0.4975
LY2
HR+
Luminal
ICRF-193
TOP2
TOP
12319.157
uM
1.06990
5.52430
0.1972 -0.3028 0.2884 0.3663
0.7639
1.0058
LY2
HR+
Luminal
ICRF-193
TOP2
TOP
10816.151
uM
inf
0.3770
0.6390 0.6502 5.0000 0.0869
0.9395
0.9672
LY2
HR+
Luminal
IKK16
IKK
NFKB
10380.093
uM
4.96840
6.12220
-0.9112 -0.9204 5.0000 0.3282
0.9978
1.4880
LY2
HR+
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
10380.092
uM
22.08650
30.64770
-0.9366 -0.9292 3.2060 0.4107
0.9976
1.4888
LY2
HR+
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7477.091
uM
22.92130
28.53740
-0.9946 -0.9956 4.9997 0.4021
0.9980
1.1485
LY2
HR+
Luminal
Ispinesib
KSP
Kinesin
7477.067
uM
0.02797
0.03324
-0.9999 -0.6861 5.0000 0.8886
0.9769
0.6787
LY2
HR+
Luminal
Ixabepilone
TUBB
TUBB
10380.095
uM
0.00555
0.00888
-0.9425 -0.5797 1.6393 0.9929
0.9335
1.4726
LY2
HR+
Luminal
JNK-IN-5A
JNK
JNK
10816.144
uM
1.95210
2.04450
-0.5137 -0.1287 4.9543 0.3671
0.7409
0.9146
LY2
HR+
Luminal
JNK-IN-5A
JNK
JNK
12319.168
uM
0.51624
0.69972
-0.6500 -0.6240 2.6635 0.7125
0.9962
0.9560
LY2
HR+
Luminal
L-779450
BRAF
MAPK
12319.166
uM
inf
inf
0.6126 0.6126 0.0000 0.2273
0.0745
1.3789
LY2
HR+
Luminal
L-779450
BRAF
MAPK
10816.149
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.4545
LY2
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7477.098
uM
inf
inf
0.7778 0.7778 0.0000 0.0908
-0.0575
1.4247